-
Paired diagnostic and relapse medulloblastoma sequencing
Study
EGAS00001007120
-
Spatial and temporal transcriptomics of medulloblastoma with chromothripsis identifies multiple genetic clones that resist to treatment and lead to relapse
Study
EGAS00001007128
-
Monocyte Spike-in RNASeq
Study
EGAS00001007197
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Multiomic profiling of pleomorphic rhabdomyosarcoma
Study
EGAS00001007230
-
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Study
EGAS00001007245
-
Transcriptomic analysis of cell-of-origin CNS neuroblastoma, FOXR2 activated
Study
EGAS00001007247
-
Spatial tumor microenvironment characterization and outcome of relapsed/refractory classic Hodgkin lymphoma
Study
EGAS00001007261
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
WES of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007301
-
'IL-17A-Producing ILC3s and Duodenal Adenoma in FAP'
Study
EGAS00001007347
-
shallow WGS and deep targeted panel on ctDNA in rhabdomyosarcomas
Study
EGAS00001007399
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types
Study
EGAS00001007412
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types (RNAseq)
Study
EGAS00001007428
-
Epithelioid haemangioendothelioma (EHE) case series from the Stafford Fox Rare Cancer Program
Study
EGAS00001007474
-
Machine Learning Signal Enrichment for Ultrasensitive Plasma Tumor Burden Monitoring
Study
EGAS00001007451
-
Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580
Study
EGAS00001007466
-
Single-cell profiling of co-cultures of GSCCs and macrophages
Study
EGAS00001007482
-
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
Study
EGAS00001007486
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Sequential Antigen-loss and Branching Evolution in Lymphoma after Anti-CD19 and Anti-CD20 Targeted T Cell Engaging Immunotherapy
Study
EGAS00001007561
-
Complex structural variation patterns in pediatric solid tumors
Study
EGAS00001007565
-
Single-cell RNA-seq of peripheral blood mononuclear cells in classic Hodgkin lymphoma
Study
EGAS00001007569
-
Single-cell RNA-sequencing of a multi-region pleural mesothelioma case
Study
EGAS00001008062
-
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Study
EGAS00001007611
-
Early evolutionary branching across spatial domains predisposes to clonal replacement under chemotherapy in neuroblastoma
Study
EGAS00001007650
-
Comprehensive Deep Sequencing Atlas in HCC tumors
Study
EGAS00001007694
-
NOTCH1 fusion genes in pediatric T-cell lymphoblastic lymphoma hallmark a common high-risk subgroup with blood TARC levels as possible biomarker
Study
EGAS00001007703
-
noninvasive lung cancer subtyping
Study
EGAS00001007717
-
Pharmacogenomic Analysis Reveals New Therapeutic Options for Pleural Mesothelioma
Study
EGAS00001007866
-
Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
Study
EGAS00001007002
-
Novel paediatric case of a spinal high-grade astrocytoma with piloid features in a patient with Noonan Syndrome
Study
EGAS00001007937
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Three-dimensional patient-derived models of glioblastoma retain intra-tumoral heterogeneity
Study
EGAS00001008023
-
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target
Study
EGAS00001008039
-
Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma
Study
EGAS00001008059
-
Brain_Disease_Wellcome_Leap_Delta_Tissue_ATAC
Study
EGAS00001008083
-
Cross-species Comparison Reveals Therapeutic Vulnerabilities Halting Glioblastoma Progression
Study
EGAS00001008155
-
Influence of age on molecular changes and treatment stratification in multimodal glioblastoma therapy
Study
EGAS00001008246
-
Molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation (N2M2/NOA-20 phase I/IIa umbrella trial)
Study
EGAS00001008033
-
Integrative Multi-Omics and Drug Sensitivity Profiling Reveals Potential Predictive Biomarkers in Pediatric Solid Tumors from the INFORM Registry
Study
EGAS00001008249
-
Javelin head and neck 100
Dataset
EGAD00001011290
-
Whole-exome sequencing laser capture micro-dissected biopsies of human renal cell carcinoma
Dataset
EGAD00001008029
-
Multi-region RNA-Seq data of 10 neuroblastoma cases
Dataset
EGAD00001008133
-
Esophageal adenocarcinoma plasma cfDNA samples - PERFECT cohort and nCRT cohort
Dataset
EGAD00001008316
-
GEX CITE-Seq performance dataset
Dataset
EGAD00001008418
-
Molecular and clinical diversity in primary central nervous system lymphoma: a LOC network multi-omic PCNSL study
Dataset
EGAD00001008706